Why Gastroenterology Billing Is Complex
GI practices face unique billing challenges spanning screening, diagnostic, and therapeutic procedures — each with distinct coding rules, modifier requirements, and payer policies.
Screening vs. Diagnostic Colonoscopy
Colonoscopy coding (45378-45398) requires precise distinction between screening and diagnostic indications. Screening colonoscopies may be covered at 100% with no patient cost-share under the ACA, while diagnostic colonoscopies fall under the patient's deductible and coinsurance. When a screening becomes diagnostic (polyp removal), proper coding with modifier PT (colorectal cancer screening converted to diagnostic) and diagnosis linkage is critical for correct payment.
EGD & Upper GI Coding
Upper GI endoscopy coding (43200-43239) varies by extent of examination, with or without biopsy (43239), control of bleeding (43227-43228), dilation (43220-43226, 43248-43249), and foreign body removal (43247). Proper coding requires detailed documentation of anatomic extent, therapeutic interventions performed, and correct modifier usage for multiple procedures during the same session.
Capsule Endoscopy & ERCP
Capsule endoscopy (91110-91111) requires knowledge of distinct esophagus, small bowel, and colon capsule codes, plus proper use of G-code modifiers for Medicare. ERCP coding (43260-43278) is among the most complex GI procedures, requiring distinction between diagnostic and therapeutic components, with separate codes for sphincterotomy, stone removal, stent placement, and biopsy.
IBD Biologic Therapy Management
Inflammatory bowel disease biologic therapies (infliximab/Remicade, vedolizumab/Entyvio, ustekinumab/Stelara) require complex J-code billing (J1745, J3380), infusion administration coding (96413-96417), and careful management of prior authorizations, step therapy protocols, and medical necessity documentation. Proper billing also requires tracking infusion duration and number of units administered.